Warm Greetings!!!

Welcome to yet another interesting and informative edition of our newsletter!

It has been my privilege to reach you on the 1st & 17th of every month for the last 13 years. Please feel free to share your comments on this edition to enable us to improve constantly. In case you have missed any of our previous issues, you can find them on our website www.jagograhakjago.com or in the News Archive section of every issue of The Prescription. You can also look us up on Facebook.

Stay Healthy. Stay Protected.
Pyush Misra
Editor-in-Chief

"Standardization of data sources will enable more accurate measurement of the impact of health investments, facilitate cross-sectoral analysis, and create a foundation for evidence-based policy making."

 
Smt. Anupriya Patel

Minister of Health and Family Welfare, Government of India

New Delhi: While disposing of a batch of more than 100 petitions moved on behalf of patients suffering from Rare diseases, the Delhi High Court said that the Right to health is an integral part of the right to life. Read More...

The Union Ayush Ministry on Tuesday (October 08, 2024) said it was illegal to advertise Ayurveda, Siddha, Unani, and Homeopathy drugs claiming "miraculous or supernatural effects" for the treatment of diseases, stating such advertisements can "mislead and endanger" public health.Read More...

New Delhi: A total of 170 AYUSH treatment packages will soon be included in the government's flagship Ayushman Bharat health insurance scheme, Ayush minister Prataprao Jadhav said on Friday, adding that consultations are in the final stage. The minister also said that to guarantee easy access to Ayush medications, special medical stores on the lines of 'Janaushadhi Kendras' would be set up at tehsil level.Read More...

New Delhi: The government has made QR codes mandatory on all vaccines, in a bid to prevent counterfeits and validate the authenticity, the Drug Controller General of India (DCGI) on Wednesday told ET. Read More...

New Delhi: The Drugs Controller General of India (DCGI) is planning to list the qualification criteria for medical device testing officers. At present, no qualification is needed, with mostly drugs inspectors deputed to do the job. Read More...

New Delhi: Several doctors' associations condemned the murder of a 55-year-old medic on Thursday, saying "doctors are sitting on deathbeds" and called for immediate action to ensure their safety. According to police, Javed Akhtar, a Unani (BUMS) practitioner was shot dead in his hospital cabin at NIMA Hospital in southeast Delhi's Kalindi Kunj area around 1.45 am. The accused, both juveniles, had come for treatment. Read More...

Exports of India's pharmaceutical and meditech sectors are expected to sustain the growth momentum in the ongoing fiscal despite a slowdown in the global economy, a senior government official said on Wednesday. With the government revving up support for drug development in India, as many as 16 blockbuster molecules targeted for a wide range of therapeutic areas, including cancer, diabetes, HIV and tuberculosis, are in the pipeline to be produced in India, Department of Pharmaceuticals, Secretary Arunish Chawla told reporters on the sidelines of CII Pharma and Life Sciences summit here. Read More...

New York: When researchers discovered enough proof that a medication used to treat bone marrow cancer and Kaposi sarcoma is safe and effective in treating hereditary hemorrhagic telangiectasia (HHT), a rare bleeding disorder that affects 1 in 5,000 people worldwide, they decided to terminate an early clinical trial funded by the National Institutes of Health (NIH). Read More...

New Delhi: In a significant step towards bolstering India's clinical research capabilities, the Indian Council of Medical Research (ICMR) has signed Memorandum of Agreement (MoAs) with key industry players to conduct First-in-Human Phase-I Clinical Trials for four promising therapeutic candidates under its Phase 1 Clinical Trial Network. Read More...

The sales and distribution of Emergency Contraceptive Pill (ECP) brands, including i-Pill and Unwanted - 72, will remain unchanged, sources with the Central Drugs Standard Control Organisation (CDSCO) said on Friday. This comes after various media reports suggested a proposed change in rules by the Central Drugs Standard Control Organisation (CDSCO) regarding over-the-counter sale of ECPs. One of the reports had suggested that an “expert panel proposes a prescription requirement for the morning-after pill.” Read More...

London: Researchers at the University of Sheffield have been awarded funding for their infectious disease technology that could make life-saving vaccines more readily available to the world. Read More...

 

New Delhi: Whenever people discuss healthcare in India the argument often circles back to core issues that is the accessibility and affordability of such efforts, but for society like ours, where the socio-economic stratification dictates the access to medical interventions confronting such issues is both inevitable and indispensable. Read More...

Disruptive technologies such as AI, digital diagnostics and therapeutics, and machine learning (ML) are revolutionising healthcare by enabling unprecedented growth and innovation. Read More...

Yes, as many a times patient is unaware of the situation, because it doesn’t cause any symptoms, that’s why patients generally presents late, when hypertension had already created fatal complications in them. That’s why hypertension is called “SILENT KILLER”. In order to avoid this, regular visit to a physician for proper BP monitoring is necessary.

Lucknow: A recent study conducted by faculty at Indian Institute of Management Lucknow tackles the critical issue of low menstrual cup adoption rates in developing countries, particularly in India, despite their numerous benefits. Read More...

New Delhi: An analysis of calls received on Tele- Manas - India's toll-free mental health helpline - has revealed that most people call for complaints related to disturbed sleep cycle. Since its launch in October 2022, Tele-Manas has attended to over 3.5 lakh calls from citizens across the country. Read More...

Patient Safety And Access Initiative of India Foundation
B306, First Floor, C R Park, New Delhi -110019
www.jagograhakjago.com
Disclaimer: Our newsletter endeavors to compile patient safety information from various sources. PSAIIF may not be held responsible for any article published in The Prescription.

We request our esteemed readers to write to us at bejonmisra@jagograhakjago.com with your feedback and suggestions on what you would like us to feature in the newsletter.